Universe Pharmaceuticals (UPC) Competitors $4.78 +0.40 (+9.13%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. EVFM, GRI, APVO, WINT, ATXI, VIRX, SYRS, BIOR, MYMD, and SRNEShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Evofem Biosciences (EVFM), GRI Bio (GRI), Aptevo Therapeutics (APVO), Windtree Therapeutics (WINT), Avenue Therapeutics (ATXI), Viracta Therapeutics (VIRX), Syros Pharmaceuticals (SYRS), Biora Therapeutics (BIOR), MyMD Pharmaceuticals (MYMD), and Sorrento Therapeutics (SRNE). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Evofem Biosciences GRI Bio Aptevo Therapeutics Windtree Therapeutics Avenue Therapeutics Viracta Therapeutics Syros Pharmaceuticals Biora Therapeutics MyMD Pharmaceuticals Sorrento Therapeutics Universe Pharmaceuticals (NYSE:UPC) and Evofem Biosciences (NASDAQ:EVFM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Does the media favor UPC or EVFM? In the previous week, Universe Pharmaceuticals' average media sentiment score of 0.00 equaled Evofem Biosciences'average media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral Evofem Biosciences Neutral Is UPC or EVFM more profitable? Universe Pharmaceuticals has a net margin of 0.00% compared to Evofem Biosciences' net margin of -46.42%. Universe Pharmaceuticals' return on equity of 0.00% beat Evofem Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Evofem Biosciences -46.42%-91.97%-61.93% Do institutionals & insiders believe in UPC or EVFM? 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.2% of Evofem Biosciences shares are owned by institutional investors. 57.4% of Universe Pharmaceuticals shares are owned by company insiders. Comparatively, 0.2% of Evofem Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, UPC or EVFM? Evofem Biosciences has lower revenue, but higher earnings than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$26.73M0.01-$6.16MN/AN/AEvofem Biosciences$11.39M0.09$52.98M-$0.21-0.04 Which has more risk and volatility, UPC or EVFM? Universe Pharmaceuticals has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Comparatively, Evofem Biosciences has a beta of -0.87, suggesting that its stock price is 187% less volatile than the S&P 500. Does the MarketBeat Community prefer UPC or EVFM? Evofem Biosciences received 262 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformUniverse PharmaceuticalsN/AN/AEvofem BiosciencesOutperform Votes26269.50% Underperform Votes11530.50% SummaryUniverse Pharmaceuticals beats Evofem Biosciences on 6 of the 10 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$188,000.00$6.89B$5.57B$18.96BDividend YieldN/A3.05%5.11%4.03%P/E RatioN/A7.4422.4432.71Price / Sales0.01242.70394.0927.84Price / CashN/A65.8538.1817.53Price / Book0.036.516.774.47Net Income-$6.16M$143.21M$3.22B$1.02B7 Day Performance25.79%1.98%1.49%0.50%1 Month Performance67.13%6.89%4.00%-2.83%1 Year Performance-99.65%-2.52%16.21%4.36% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$4.78+9.1%N/A-99.7%$188,000.00$26.73M0.00220Gap DownEVFMEvofem BiosciencesN/A$0.01-4.4%N/A-37.1%$975,000.00$11.39M-0.01120GRIGRI Bio2.3425 of 5 stars$1.78-2.2%$115.50+6,388.8%-98.1%$934,000.00N/A-0.151Positive NewsAPVOAptevo Therapeutics2.3531 of 5 stars$0.61-9.3%$10,952.00+1,789,442.5%-99.9%$893,000.00$3.11M0.0050Upcoming EarningsGap DownWINTWindtree Therapeutics2.2729 of 5 stars$1.14-5.8%$350.00+30,601.8%-99.5%$854,000.00N/A-0.0730Positive NewsGap DownATXIAvenue Therapeutics1.2153 of 5 stars$0.23-8.7%N/A-95.2%$820,000.00N/A0.014VIRXViracta Therapeutics1.123 of 5 stars$0.02-12.3%$4.06+20,949.2%-97.4%$767,000.00N/A-0.0220Gap DownSYRSSyros Pharmaceuticals2.1151 of 5 stars$0.03-18.8%$3.33+12,720.5%-99.4%$698,000.00$386,000.00-0.01120Analyst ForecastGap DownBIORBiora TherapeuticsN/A$0.13flat$23.00+17,592.3%-97.9%$588,000.00$892,000.00-0.01120Gap UpMYMDMyMD PharmaceuticalsN/A$0.22+14.6%N/A-92.8%$521,000.00N/A0.006Positive NewsHigh Trading VolumeSRNESorrento TherapeuticsN/A$0.00-10.0%N/A-94.4%$496,000.00$60.32M0.00800Gap Down Related Companies and Tools Related Companies EVFM Alternatives GRI Alternatives APVO Alternatives WINT Alternatives ATXI Alternatives VIRX Alternatives SYRS Alternatives BIOR Alternatives MYMD Alternatives SRNE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPC Stock Free UPC Stock Alerts